1. Effect of Sirt3 on retinal pigment epithelial cells in high glucose through Foxo3a/ PINK1-Parkin pathway mediated mitophagy
    Li Huang et al, 2022, Experimental Eye Research CrossRef
  2. Autophagy signals orchestrate chemoresistance of gynecological cancers
    Chit Tam et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  3. Resveratrol reverses TGF‐β1‐mediated invasion and metastasis of breast cancer cells via the SIRT3/AMPK/autophagy signal axis
    Jia Wang et al, 2023, Phytotherapy Research CrossRef
  4. Cancer‐associated fibroblast‐secreted miR‐421 promotes pancreatic cancer by regulating the SIRT3/H3K9Ac/HIF‐1α axis
    Bin Zhou et al, 2022, The Kaohsiung Journal of Medical Sciences CrossRef
  5. Sirt3 activates autophagy to prevent DOX-induced senescence by inactivating PI3K/AKT/mTOR pathway in A549 cells
    Xuhong Fan et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
  6. CRIF1 promotes the progression of non-small-cell lung cancer by SIRT3- mediated deacetylation of PYCR1
    Qi Wang et al, 2022, Journal of Molecular Histology CrossRef
  7. Redox modulation of vitagenes via plant polyphenols and vitamin D: Novel insights for chemoprevention and therapeutic interventions based on organoid technology
    Maria Scuto et al, 2021, Mechanisms of Ageing and Development CrossRef
  8. COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?
    Antonio Macciò et al, 2021, Journal of Ovarian Research CrossRef
  9. Evaluation of ARK5 and SIRT3 expression in renal cell carcinoma and their clinical significance
    Noha Elkady et al, 2023, Diagnostic Pathology CrossRef
  10. The role of protein acetylation in carcinogenesis and targeted drug discovery
    Jingru Yang et al, 2022, Frontiers in Endocrinology CrossRef
  11. SIRT3 regulates mitochondrial function: A promising star target for cardiovascular disease therapy
    Qin Zhang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  12. Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
    Fengyi Guo et al, 2022, Frontiers in Oncology CrossRef